Tag Archives: Ability

CellCept: 250 mg Capsules, 500 mg Tablets. Myfortic: 180, 360 mg Tablets

Mycophenolate Mofetil (mye-koe-fee-noe-late moe-fe-til) [CellCept] Mycophenolic Acid (mye-koe-fee-noe-lik) [Myfortic] Drug Classification (The therapeutic classification, which categorizes drugs by the disease state they are used to treat, appears first, followed by the pharmacologic classification, which is based on the drug’s mechanism of action.) Therapeutic class: immunosuppressants Pregnancy Category (pregnancy categories (A, B, C, D, and X)… Read More »

Psychoactive Substance Use Disorders and Suicide

Diagnosis and treatment Practical guidelines for the assessment and treatment of patients with SUDs have been published by the American Psychiatric Association (APA) and by the National Institute for Health and Care Excellence (NICE), and reported several forms of beneficial therapy including both somatic and psychological treatments. The duration of treatment may vary, but to… Read More »

Lamotrigine: 25mg, 50mg, 100mg, 150mg, 200mg, 250mg. Uses and Administration

Lamotrigine, a phenyltriazine compound, is an antiepileptic used mainly for monotherapy or adjunctive treatment of partial seizures and primary and secondarily generalised tonic-clonic seizures. It may be used for seizures associated with the Lennox-Gastaut syndrome and for the maintenance treatment of bipolar disorder. The doses given below for the use of lamotrigine in epilepsy are… Read More »

Carbamazepine: 100mg, 200mg, 300mg, 400mg. Uses and Administration

Carbamazepine is a dibenzazepine derivative with antiepileptic and psychotropic properties. It is used to control secondarily generalised tonic-clonic seizures and partial seizures, and in some primary generalised seizures. Carbamazepine is also used in the treatment of trigeminal neuralgia and has been tried with variable success in glossopharyngeal neuralgia and other severe pain syndromes associated with… Read More »

Pharmacological Treatment of Dementia

General guidelines for psychotropic medication use in frail elderly patients are applicable. Systematic evidence to support the effectiveness of particular psychotropic drugs in dementia patients is limited. Therefore, choice of drug class may be based on clinical evidence, and choice of agent is often based on the side-effect profile and on the characteristics of a… Read More »

Mixed Dementia and Dementia in Disseminated Brain Diseases

Vascular Dementia Vascular dementia is defined as the dementia resulting from ischemic, ischemic-hypoxic, or hemorrhagic brain lesions due to cerebrovascular or cardiovascular pathology. Clinical findings in vascular dementia are heterogeneous and depend to a great extent on the speed, total volume, and localization of the lesions. Typically, the onset is in later life, and the… Read More »

Subcortical Dementias

Huntington’s Disease Huntington’s disease has the three main characteristics of the subcortical dementia syndrome, together with the classic choreoathetoid movement disorder and a positive family history. Huntington’s disease usually has its onset in the third or fourth decade, although juvenile forms occasionally occur. The psychopathology, both cognitive and noncognitive, may appear before the movement abnormalities.… Read More »

Cortical Dementias

Alzheimer’s Disease Most cases of Alzheimer’s disease start after age 65, but an earlier onset is not infrequent. Although some authors consider “presenile” and “senile” clinical forms to be different diseases, most consider them the same disorder with varied age at onset. The characteristic general dementia syndrome has been described and includes the cortical signs… Read More »

Suicide in the Medically Ill

Physical disease is present in a high proportion of people who commit suicide. A recent review cited several large studies that reported that medical illness was present in 30%-40% of the patients who committed suicide. However, most of these suicides do not occur during medical hospitalization. About 2% of Finnish suicides occurred in medical or… Read More »

Managing at Work When You Are Depressed

My worst fear was that I would lose my job. I had missed more days of work in the last 2 months than I had in the last 2 years. Because of my sleep problems, I was tired and irritable all the time and I felt less productive. I was running behind in my paperwork… Read More »